Collection : Essential
Last update : 08/04/2024
Price : 600 €
Number of pages : 23 pages
Language : English
Format : PDF (immediate availability)
Reference : 24XENT20
IN THIS XERFI GLOBAL REPORT :
WHAT IS THE GROUP'S FINANCIAL SITUATION ?
The financial indicators presented in this report include: consolidated revenue, consolidated EBIT and EBIT ratio, consolidated net profit and net profit rate, R&D expenditure and ratio, sales by segment and by region, profitability, liquidity and solvency ratios, free cash flow and capital expenditure.
WHAT ARE THE GROUP'S STRATEGIC PRIORITIES ?
Rebuild blockbuster pharmaceutical line-up
Defend against further litigation while maintaining a robust Crop Science portfolio
Enact major organisational restructuring
WHAT ARE THE GROUP'S STRENGTHS AND WEAKNESSES ?
Through a SWOT analysis, this report also provides an overview of the group's strengths (a major global player in agriculture, etc.) and weaknesses (significant and sustained litigation battles since Monsanto acquisition, etc.).
Presentation
Segments
SWOT
INSCRIPTION NEWSLETTER SECTORIELLE
XL’ÉTUDE A ÉTÉ AJOUTÉE A VOTRE PANIER